We are monitoring the impact of COVID-19 on Europe Bovine Respiratory Disease Treatment Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 849
Share on
Share on

Europe Bovine Respiratory Disease Treatment Market Research Report - By Type of Treatment and Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends, Forecast (2019 - 2024)

Pulished: February, 2020
ID: 849
Pages: 142

The Europe Bovine Respiratory Disease Treatment Market has been estimated at USD 9.18 million in 2019 and is projected to reach USD 23.34 million by 2024, at a CAGR of 20.5% during the forecast period from 2019 to 2024.

There is a huge influence of bovine respiratory disease (BRD), diarrhea, arthritis and otitis on the economically significant parameters of mortality, hot carcass weight (HCW), carcass quality, fat cover and meat color which produces a problem for the cattle production.

BRD is a complex multifactorial disease that involves an interaction between several factors. In the current scenario, body temperature has been used to determine whether treatment should be done or not. Body temperature is such an important diagnostic test that many feedlots will treat animals based upon an undifferentiated fever. 

A combination of disease organisms is usually accountable for respiratory infection and illness, but other factors also affect the animal’s health. Environmental factors, particularly transport, have been associated with BRD; the weather has always been implicated in the occurrence of the disease. It has been concluded that stressful events, and others like calving or an overenthusiastic introduction to high grain rations, may precipitate cases of BRD.

This research report segmented and sub-segmented the Europe Bovine Respiratory Disease Treatment Market into the following categories:

  • By Treatment Type: Anti – Infectious Agents (antibiotics and sulpha), Anti – parasiticides, bronchodilators, oral rehydration fluids, non-steroidal anti-inflammatories, and mucolytic.
  • By Country: UK, France, Spain, Germany, Italy,  Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe

Few of the promising companies operating in the Europe Bovine Respiratory Disease Treatment Market are Zoetis Inc., Merck & Co. Inc., Bayer Corporation, Eli Lilly & Co, Merial S.A.S, Boehringer Ingelheim Vetmedica, Novartis Animal Health, Vibrac S.A., Ceva Sante Animale and Vétoquinol S.A

1. Introduction                                                 

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                           

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                              

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                            

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                     

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                      

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                      

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                               

5. Market Segmentation                                                              

                5.1 By Type of Treatment                                            

                                5.1.1 Anti-Infectious Agents                       

                                                5.1.1.1 Antibiotics           

                                                5.1.1.2 Sulfas    

                                5.1.2 Anti-Parasiticides                 

                                5.1.3 Bronchodilators                    

                                5.1.4 Oral Rehydration Fluids                     

                                5.1.5 Non-Steroidal Anti-Inflammatories               

                                5.1.6 Mucolytics                              

6. Geographical Analysis                                                              

                                6.1 Introduction                              

                                6.2 U.K                

                                6.3 Spain                             

                                6.4 Germany                     

                                6.5 Italy                               

                                6.6 France                          

7. Strategic Analysis                                                       

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                      

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services               

                                7.2.5 Competitive Rivalry within the Industry                      

8. Market Leaders' Analysis                                                        

                8.1 Zoetis Inc.                                   

                                8.1.1 Overview                

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                            

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Merck & Co. Inc.                                       

                8.3 Bayer Corporation                                   

                8.4 Eli Lilly & Co.                                              

                8.5 Merial S.A.S                               

                8.6 Boehringer Ingelheim Vetmedica                                     

                8.7 Novartis Animal Health                                          

                8.8 Vibrac S.A                                   

                8.9 Ceva Sante Animale                                

                8.10 Vétoquinol S.A.                                      

9. Competitive Landscape                                                           

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                        

                9.3 Agreements, collaborations and Joint Ventures                                          

                9.4 New Product Launches                                          

10. Expert Opinions                                                        

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Bovine Respiratory Disease Treatment Market By Region, From 2019 - 2024 (USD Million)
  2. Europe Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2019 - 2024 (USD Million)
  3. Europe Anti-Infectious Agents Market By Region, From 2019 - 2024 (USD Million)
  4. Europe Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2019 - 2024 (USD Million)
  5. Europe Antibiotics Market By Region, From 2019 - 2024 (USD Million)
  6. Europe Sulfas Market By Region, From 2019 - 2024 (USD Million)
  7. Europe Anti-Parasiticides Market By Region, From 2019 - 2024 (USD Million)
  8. Europe Bronchodilators Market By Region, From 2019 - 2024 (USD Million)
  9. Europe Oral Rehydration Fluids Market By Region, From 2019 - 2024 (USD Million)
  10. Europe Non-Steroidal Anti-Inflammatories Market By Region, From 2019 - 2024 (USD Million)
  11. Europe Mucolytic Market By Region, From 2019 - 2024 (USD Million)
  12. U.K Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2019 - 2024 (USD Million)
  13. U.K Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2019 - 2024 (USD Million)
  14. Spain Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2019 - 2024 (USD Million)
  15. Spain Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2019 - 2024 (USD Million)
  16. Germany Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2019 - 2024 (USD Million)
  17. Germany Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2019 - 2024 (USD Million)
  18. Italy Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2019 - 2024 (USD Million)
  19. Italy Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2019 - 2024 (USD Million)
  20. France Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2019 - 2024 (USD Million)
  21. France Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2019 - 2024 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample